Trademark: 79142345
Status Date
Sunday, September 3, 2023
Registration Number
4661507
Registration Date
Tuesday, December 30, 2014
Filing Date
Wednesday, September 4, 2013
Published for Opposition
Tuesday, October 14, 2014
Cancellation Date
Monday, September 4, 2023
41 Training services in the field of medicine and clinical trials; publishing writing and publication of books and texts other than advertising texts; non-downloadable electronic publication of texts in the nature of articles, magazines, brochures in the field of online medicine; educational services, namely, organization and conducting of colloquiums, conferences, conventions, seminars in the field of medicine; teaching in the field of medicine and clinical trials
35 Creation, compilation, management of databases and central data files in the field of medicine and clinical trials Database management, collection and compilation of information into computer databases in the field of medicine and clinical trials; compilation of statistics; compilation and systematization of data into a central file; public relations; business information, namely, provision of commercial information in the fields of pharmaceutical products and medical and scientific research in the field of pharmaceutical products and clinical trials
44 Medical services; pharmacy advice; Providing information about the diagnosis and treatment of neurological diseases, Charcot-Mary-Tooth disease, Alzheimer's disease, Parkinson's disease, idiopathic neuropathy, diabetic neuropathy, toxic neuropathy, amyothrophic lateral sclerosis, multiple sclerosis, multiple system atrophy and metabolic disease including diabetes type II, medicines, namely, medicines for the treatment of neurological diseases, Charcot-Mary-Tooth disease, Alzheimer's disease, Parkinson's disease, idiopathic neuropathy, diabetic neuropathy, toxic neuropathy, amyothrophic lateral sclerosis, multiple sclerosis, multiple system atrophy and metabolic disease including diabetes type II, and awareness and information regarding the treatment regarding the aforementioned diseases and illnesses
42 Pharmaceutical research and development; scientific research for medical purposes in the field of medicine and clinical trials; Scientific and clinical research studies in the fields of medicine, the prevention, treatment and management of illness, health care delivery; chemical and biological analysis, research in chemistry, cosmetology, biology, bacteriology, nutrition, biotechnology; biological research for the diagnosis, prevention and treatment of diabetes and obesity and any other illness; biological research services in the field of chemical, biological and pharmaceutical products; software design and development; scientific laboratory services; research on chemical reagents for medical use, namely, biomarkers
Color is not claimed as a feature of the mark.
The wording "PLEOTREATMENT" has no meaning in a foreign language.
Mar 31, 2024
Notification Of Effect Of Cancellation Of Intl Reg E-Mailed
Mar 31, 2024
Notification Of Effect Of Cancellation Of Intl Reg E-Mailed
Mar 31, 2024
Death Of International Registration
Aug 8, 2022
Total Invalidation Processed By The Ib
Jul 7, 2022
Total Invalidation Of Reg Ext Protection Sent To Ib
Jul 7, 2022
Invalidation Processed
Mar 16, 2022
Total Invalidation Of Reg Ext Protection Created
Jul 16, 2021
Cancelled Section 71
Dec 30, 2019
Courtesy Reminder - Sec. 71 (6-Yr) E-Mailed
Jul 7, 2017
New Representative At Ib Received
Jun 8, 2017
New Representative At Ib Received
May 26, 2017
New Representative At Ib Received
May 8, 2015
Final Decision Transaction Processed By Ib
Apr 1, 2015
Final Disposition Notice Sent To Ib
Apr 1, 2015
Final Disposition Processed
Mar 30, 2015
Final Disposition Notice Created, To Be Sent To Ib
Dec 30, 2014
Registered-Principal Register
Oct 24, 2014
Notification Processed By Ib
Oct 14, 2014
Official Gazette Publication Confirmation E-Mailed
Oct 14, 2014
Published For Opposition
Oct 8, 2014
Notification Of Possible Opposition Sent To Ib
Oct 8, 2014
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Sep 24, 2014
Notification Of Notice Of Publication E-Mailed
Sep 10, 2014
Law Office Publication Review Completed
Sep 10, 2014
Approved For Pub - Principal Register
Sep 10, 2014
Examiner's Amendment Entered
Sep 10, 2014
Notification Of Examiners Amendment E-Mailed
Sep 10, 2014
Examiners Amendment E-Mailed
Sep 10, 2014
Examiners Amendment -Written
Sep 3, 2014
Teas/Email Correspondence Entered
Sep 3, 2014
Correspondence Received In Law Office
Aug 27, 2014
Assigned To Lie
Aug 25, 2014
Teas Response To Office Action Received
Jul 31, 2014
Attorney/Dom.Rep.Revoked And/Or Appointed
Jul 31, 2014
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Mar 14, 2014
Refusal Processed By Ib
Feb 25, 2014
Non-Final Action Mailed - Refusal Sent To Ib
Feb 25, 2014
Refusal Processed By Mpu
Feb 25, 2014
Non-Final Action (Ib Refusal) Prepared For Review
Feb 25, 2014
Application Filing Receipt Mailed
Feb 24, 2014
Non-Final Action Written
Feb 21, 2014
Assigned To Examiner
Feb 21, 2014
New Application Office Supplied Data Entered
Feb 19, 2014
Limitation From Original Application Entered
Feb 17, 2014
Sn Assigned For Sect 66a Appl From Ib
Trademark Alertz updated from USPTO on 2030-01-24
